IARNA
IARNA is a NPO that disseminates information on IARNA was one of the first UK based hosting companies, offering a fully automated control panel and provisioning software. IARNA was founded in 1997 by Rob Lovell.
IARNA
Social Links:
Industry:
Health Care Information Technology
Founded:
1997-01-01
Website Url:
http://www.iarna.com
Total Employee:
11+
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API WordPress Font Awesome Apache Wordpress Plugins COVID-19 WordPress 5.9
Founder
Official Site Inspections
http://www.iarna.com
- Host name: a904c694c05102f30.awsglobalaccelerator.com
- IP address: 13.248.169.48
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "IARNA"
AIRNA - Crunchbase Company Profile & Funding
Organization. AIRNA . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... AIRNA is a biotech company that is pioneering RNA editing therapies to improve the health of individuals โฆSee details»
ABOUT US - AIRNA
โRNA editing has unique potential to make transformative medicines for many patientsโSee details»
NEWS - AIRNA
Financing led by Forbion and includes participation from ARCH Venture Partners and a broad syndicate of world-class investors New funds will advance product candidate for the treatment โฆSee details»
AIRNA Company Profile 2024: Valuation, Funding
AIRNA General Information Description. Developer of a ribonucleic acid (RNA) editing platform designed for healthcare professionals. The company's platform is developing RNA editing therapeutics created to maximize therapeutic โฆSee details»
AIRNA Raises Oversubscribed $60 Million Financing to Advance โฆ
Jul 31, 2024 CAMBRIDGE, Mass. & TÜBINGEN, Germany, July 31, 2024--AIRNA announces the successful closing of an oversubscribed $60 million financing round, which brings the total โฆSee details»
AIRNA - Forbion
AIRNAโs powerful and flexible RNA editing platform, RESTORE+โข, is designed to restore a patientโs health by creating genetic medicines for rare and common diseases. RESTORE+โข โฆSee details»
AIRNA - Funding, Financials, Valuation & Investors
Sep 19, 2023 AIRNA is a biotech company that is pioneering RNA editing therapies to improve the health of individuals. Search Crunchbase. Start Free Trial . Chrome Extension. ... How much funding has this organization raised โฆSee details»
AIRNA - LinkedIn
AIRNA, a biotech company pioneering RNA editing therapeutics to restore the health of patients with rare and common diseases. AIRNAโs experienced team is aiming to advance a pipeline of RNA ...See details»
AIRNA Raises Oversubscribed $60 Million Financing to Advance โฆ
Jul 31, 2024 AIRNA is advancing its first therapeutic program, a best-in-class product candidate to treat the inherited genetic disease alpha-1 antitrypsin deficiency (AATD), as well as a โฆSee details»
Forbion leads Oversubscribed $60 Million Financing in AIRNA to โฆ
Jul 31, 2024 AIRNA is advancing its first therapeutic program, a best-in-class product candidate to treat the inherited genetic disease alpha-1 antitrypsin deficiency (AATD), as well as a โฆSee details»
AIRNA Company Profile - Office Locations, Competitors, Revenue โฆ
AIRNA has 5 employees across 2 locations and $30 m in total funding,. See insights on AIRNA including office locations, competitors, revenue, financials, executives, subsidiaries and more โฆSee details»
AIRNA emerges from stealth with $30M financing โ SPARK Stanford
Sep 26, 2023 AIRNA emerges from stealth with $30M financing Posted on September 26th, 2023 AIRNA, a startup company co-founded by SPARK scholars Dr. Jin Billy Li and Dr. Paul โฆSee details»
AIRNA Launches to Develop New Class of RNA Editing โฆ
Sep 19, 2023 As a first step, AIRNA is advancing development of a best-in-class product candidate to treat the inherited genetic disease alpha-1 antitrypsin deficiency. AIRNA is also โฆSee details»
AIRNA Raises Oversubscribed $60 Million Financing to Advance โฆ
Jul 31, 2024 AIRNA is advancing its first therapeutic program, a best-in-class product candidate to treat the inherited genetic disease alpha-1 antitrypsin deficiency (AATD), as well as a โฆSee details»
Biotech startup Airna raises $60M for RNA editing medicines
Jul 31, 2024 RNA editing startup Airna is adding more funds to its Series A round, raising another $60 million as it develops genetic medicines for lung, cardiovascular, metabolic and โฆSee details»
AIRNA Launches to Develop New Class of RNA Editing โฆ
Sep 19, 2023 AIRNA emerges from stealth with $30 million in financing led by ARCH Venture Partners to advance a pipeline of RNA editing therapeutics.See details»
AIRNA Raises Oversubscribed $60 Million Financing to Advance โฆ
Josh Brumm, General Partner at Forbion, to join AIRNA Board of Directors CAMBRIDGE, Mass. & TÜBINGEN, Germany, July 31, 2024-- AIRNA, a biotech company pioneering RNA editing โฆSee details»
WORKING AT AIRNA - AIRNA
We span multiple countries and believe diversity makes us stronger and helps AIRNA achieve more for patients. Careers. If you are inspired by innovation, passionate about helping โฆSee details»
AIRNA Launches to Develop New Class of RNA Editing ... - BioSpace
Sep 19, 2023 CAMBRIDGE, Mass. & TÜBINGEN, Germany--(BUSINESS WIRE)-- AIRNA, a biotech company pioneering RNA editing therapeutics to restore the health of patients with โฆSee details»